Lyophilization of Biologics: An FDA Perspective

doi:https://doi.org/10.1007/978-1-4939-2383-0_15

Book Chapter10.1007/978-1-4939-2383-0_15

Lyophilization of Biologics: An FDA Perspective

David Awotwe‐Otoo,Mansoor A. Khan-2015-01-01

4

Chat with Paper

AI Agents for this Paper

No abstract available for this paper.

Keywords

BiopharmaceuticalQuality by DesignCritical quality attributesProcess (computing)Food and drug administrationProcess analytical technologyComputer scienceBiochemical engineering

Chat

Click to start Chat